Litigating patents in investment arbitration: Eli Lilly v Canada

By Lentner G.


Eli Lilly and Company v Government of Canada, Final Award, UNCITRAL, ICSID Case No. UNCT/14/2, 16 March 2017For the first time in investment arbitration, a tribunal has ruled in a case involving the invalidation of a pharmaceutical company’s patents by Canadian courts in an investment-based claim. …read more

Source:: Journal of Intellectual Property Law & Practice